Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 4/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | AADAT | Q8N5Z0 | 1/20 | 0.33 |
| ▸ | NOS3 | P29474 | 1/20 | 0.32 |
| ▸ | NOS1 | P29475 | 1/20 | 0.32 |
| ▸ | NOS2 | P35228 | 1/20 | 0.32 |
| ▸ | HTR2A | P28223 | 1/20 | 0.32 |
| ▸ | HTR2C | P28335 | 1/20 | 0.32 |
| ▸ | HTR2B | P41595 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | HTR5A | P47898 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11674515 | 0.77 | EDNRA (0.47) | — | |
| SCHEMBL31740975 | 0.77 | EDNRA (0.47) | — | |
| SCHEMBL9113014 | 0.75 | MAOA (0.39) | GPR3MEN1KMT2AGAA | |
| SCHEMBL3236685 | 0.75 | AADAT (0.39) | GPR3MEN1KMT2AAADATNOS3 | |
| SCHEMBL3236677 | 0.75 | AADAT (0.39) | GPR3MEN1KMT2AAADATNOS3 | |
| SCHEMBL28348254 | 0.75 | MEN1 (0.33) | GPR3MEN1KMT2AUSP2AADAT | |
| SCHEMBL3236671 | 0.75 | AADAT (0.39) | GPR3MEN1KMT2AAADATNOS3 | |
| SCHEMBL18080870 | 0.73 | MAOA (0.37) | GPR3MEN1KMT2AUSP2AADAT | |
| SCHEMBL31070318 | 0.72 | GPR3 (0.39) | GPR3MEN1KMT2ANOS3NOS1 | |
| SCHEMBL18887229 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1713779-B1 | INDAZOLE DERIVATIVES AS INHIBITORS OF HORMONE-SENSITIVE LIPASES | SANOFI AVENTIS DEUTSCHLAND (DE) | 2011-04-13 | — | — | EP | claimed |
| US-20090215824-A1 | INDAZOLE DERIVATIVES AS INHIBITORS OF HORMONE SENSITIVE LIPASE | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2009-08-27 | — | — | US | claimed |
| EP-1713779-A1 | INDAZOLE DERIVATIVES AS INHIBITORS OF HORMONE-SENSITIVE LIPASES | Sanofi-Aventis Deutschland GmbH (DE) | 2006-10-25 | — | — | EP | claimed |
| US-20050197348-A1 | Indazole derivatives as inhibitors of hormone sensitive lipase | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2005-09-08 | — | — | US | claimed |
| WO-2005073199-A1 | INDAZOLE DERIVATIVES AS INHIBITORS OF HORMONE-SENSITIVE LIPASES | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2005-08-11 | — | — | WO | claimed |
| EP-0691962-A1 | 1-AMINO-3-PHENOXY PROPANE DERIVATIVES AS MODULATORS OF MULTI-DRUG RESISTANCE | BASF AKTIENGESELLSCHAFT (DE) | 1996-01-17 | — | — | EP | claimed |
| WO-1994022842-A1 | 1-AMINO-3-PHENOXY PROPANE DERIVATIVES AS MODULATORS OF MULTI-DRUG RESISTANCE | BASF AKTIENGESELLSCHAFT (DE) | 1994-10-13 | — | — | WO | claimed |
| US-4695671-A | Tetramethyltetrahydronaphthalene purification process | PHILLIPS PETROLEUM COMPANY (US) | 1987-09-22 | — | — | US | claimed |
| US-12559467-B2 | Organic light emitting device | LG CHEM, LTD. (KR) | 2026-02-24 | — | — | US | disclosed |
| US-12497415-B2 | Polycyclic compound and organic light-emitting element comprising same | LG CHEM, LTD. (KR) | 2025-12-16 | — | — | US | disclosed |
| CN-116789625-A | Main body material and preparation method thereof, luminescent layer material and organic electroluminescent device | 吉林奥来德光电材料股份有限公司 | 2023-09-22 | — | — | CN | disclosed |
| US-20230114182-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-04-13 | — | — | US | disclosed |
| US-20230092585-A1 | ORGANIC LIGHT-EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-03-23 | — | — | US | disclosed |
| US-20230090371-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-03-23 | — | — | US | disclosed |
| US-4695671-A | Tetramethyltetrahydronaphthalene purification process | PHILLIPS PETROLEUM COMPANY (US) | 1987-09-22 | — | — | US | disclosed |
| US-4568757-A | ACNE, PSORIASIS, ANTITUMOR AGENTS, VITAMIN A TYPE ACTIVITY | RESEARCH TRIANGLE INSTITUTE (US) | 1986-02-04 | — | — | US | disclosed |
| US-4568757-A | ACNE, PSORIASIS, ANTITUMOR AGENTS, VITAMIN A TYPE ACTIVITY | RESEARCH TRIANGLE INSTITUTE (US) | 1986-02-04 | — | — | US | disclosed |
| US-4178311-A | Process for the production of compounds useful in perfumery | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1979-12-11 | — | — | US | disclosed |
| US-4162256-A | Process for the production of compounds useful in perfumery | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1979-07-24 | — | — | US | disclosed |
| US-4123469-A | Process for production of bicyclic compounds | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1978-10-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12497415-B2 | Polycyclic compound and organic light-emitting element comprising same | CYBA, CRY2, CRY1 | GPR3 2062/4885MEN1 1727/4885KMT2A 2595/4885 |
| US-20090215824-A1 | INDAZOLE DERIVATIVES AS INHIBITORS OF HORMONE SENSITIVE LIPASE | LIPE, PNLIP, CEL | GPR3 1087/4885MEN1 2534/4885KMT2A 4174/4885 |
| US-20230114182-A1 | ORGANIC LIGHT EMITTING DEVICE | CRY1, CRY2, NR2E3 | GPR3 2815/4885MEN1 2887/4885KMT2A 1286/4885 |
| US-12559467-B2 | Organic light emitting device | CRY1, RPS24, ARL1 | GPR3 766/4885MEN1 514/4885KMT2A 2913/4885 |
| US-20050197348-A1 | Indazole derivatives as inhibitors of hormone sensitive lipase | LIPE, PNLIP, CEL | GPR3 1087/4885MEN1 2534/4885KMT2A 4174/4885 |
| US-20230092585-A1 | ORGANIC LIGHT-EMITTING DEVICE | CRY1, CRY2, PER2 | GPR3 2031/4885MEN1 970/4885KMT2A 2234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.